Propionylcarnitine

Propionylcarnitine is a lipid of Fatty Acyls (FA) class. Propionylcarnitine is associated with abnormalities such as Failure to Thrive. The involved functions are known as Functional disorder. Propionylcarnitine often locates in Body tissue.

Cross Reference

Introduction

To understand associated biological information of Propionylcarnitine, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Propionylcarnitine?

Propionylcarnitine is suspected in Failure to Thrive and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Propionylcarnitine

MeSH term MeSH ID Detail
Reperfusion Injury D015427 65 associated lipids
Starvation D013217 47 associated lipids
Pregnancy Complications D011248 19 associated lipids
Penile Induration D010411 4 associated lipids
Metabolism, Inborn Errors D008661 46 associated lipids
Liver Cirrhosis D008103 67 associated lipids
Erectile Dysfunction D007172 19 associated lipids
Carcinoma, Hepatocellular D006528 140 associated lipids
Body Weight D001835 333 associated lipids
Amino Acid Metabolism, Inborn Errors D000592 16 associated lipids
Total 10

PubChem Associated disorders and diseases

What pathways are associated with Propionylcarnitine

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Propionylcarnitine?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Propionylcarnitine?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Propionylcarnitine?

There are no associated biomedical information in the current reference collection.

What genes are associated with Propionylcarnitine?

There are no associated biomedical information in the current reference collection.

What common seen animal models are associated with Propionylcarnitine?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with Propionylcarnitine

Download all related citations
Per page 10 20 50 100 | Total 223
Authors Title Published Journal PubMed Link
Wu SN et al. [Analysis of propionylcarnitine in blood and methylmalonic acid in urine of 162 patients with methylmalonic acidemia]. 2013 Zhonghua Yi Xue Za Zhi pmid:23663331
Huang Z et al. [Outcomes of patients with combined methylmalonic acidemia and homocystinuria after treatment]. 2013 Zhonghua Er Ke Za Zhi pmid:23751581
Wagner CC et al. Plasma pharmacokinetics and gastrointestinal transit of a new propionyl-L-carnitine controlled release formulation. 2011 Xenobiotica pmid:21810044
Bene J et al. Changes of plasma fasting carnitine ester profile in patients with ulcerative colitis. 2006 World J. Gastroenterol. pmid:16440427
Merra G et al. Propionyl-L-carnitine hydrochloride for treatment of mild to moderate colonic inflammatory bowel diseases. 2012 World J. Gastroenterol. pmid:23049215
Ning WH and Zhao K Propionyl-L-carnitine induces eNOS activation and nitric oxide synthesis in endothelial cells via PI3 and Akt kinases. 2013 Sep-Oct Vascul. Pharmacol. pmid:23850990
Capecchi PL et al. Carnitines increase plasma levels of adenosine and ATP in humans. 1997 Vasc Med pmid:9546959
Taylor DJ et al. Changes in energy metabolism of calf muscle in patients with intermittent claudication assessed by 31P magnetic resonance spectroscopy: a phase II open study. 1996 Vasc Med pmid:9552578
Brass EP et al. A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication. 2013 Vasc Med pmid:23321261
Mingorance C et al. Critical update for the clinical use of L-carnitine analogs in cardiometabolic disorders. 2011 Vasc Health Risk Manag pmid:21490942
Cavallini G et al. Acetyl-L-carnitine plus propionyl-L-carnitine improve efficacy of sildenafil in treatment of erectile dysfunction after bilateral nerve-sparing radical retropubic prostatectomy. 2005 Urology pmid:16286128
Giovannini L et al. Acute CYA-induced ATP depletion is prevented by pretreatment with L-propionylcarnitine in isolated and perfused rat kidney. 1998 Transplant. Proc. pmid:9723376
Luo T et al. A study on the efficacy and safety assessment of propionyl-L-carnitine tablets in treatment of intermittent claudication. 2013 Thromb. Res. pmid:23998557
Morand R et al. Effect of short- and long-term treatment with valproate on carnitine homeostasis in humans. 2012 Ther Drug Monit pmid:22743351
Stroh R et al. L-propionyl carnitine, an endogenous ester in fatty acid metabolism, exerts anti-shock and endothelial protective effects in rat splanchnic ischemia-reperfusion injury. 1998 Shock pmid:9525330
Vermeulen RC and Scholte HR Exploratory open label, randomized study of acetyl- and propionylcarnitine in chronic fatigue syndrome. 2004 Mar-Apr Psychosom Med pmid:15039515
Scioli MG et al. Propionyl-L-Carnitine Enhances Wound Healing and Counteracts Microvascular Endothelial Cell Dysfunction. 2015 PLoS ONE pmid:26473356
Mingorance C et al. Propionyl-L-carnitine corrects metabolic and cardiovascular alterations in diet-induced obese mice and improves liver respiratory chain activity. 2012 PLoS ONE pmid:22457831
Vargiu R et al. Enhancement of muscular performance by a coformulation of propionyl-L-carnitine, coenzyme Q10, nicotinamide, riboflavin and pantothenic acid in the rat. 2002 Physiol. Behav. pmid:12044598
Valoti M et al. Effects of carnitine and its derivatives on gastric acid secretion in rats. 1996 Nov-Dec Pharmacol. Res. pmid:9076846
Palomba D et al. Metabolic and renal effects of Laevo-carnitine and propionyl-carnitine in rats with subtotal nephrectomy. 1996 Sep-Oct Pharmacol. Res. pmid:9051710
Caruso A et al. Protective effect of propionyl-L-carnitine against PAF-induced rat paw oedema. 1995 Pharmacol. Res. pmid:7784308
Signorelli SS et al. Effects of ischaemic stress on leukocyte activation processes in patients with chronic peripheral occlusive arterial disease: role of L-propionyl carnitine administration. 2001 Pharmacol. Res. pmid:11592865
Sayed-Ahmed MM et al. Propionyl-L-carnitine as protector against adriamycin-induced cardiomyopathy. 2001 Pharmacol. Res. pmid:11419959
Arafa HM and Sayed-Ahmed MM Protective role of carnitine esters against alcohol-induced gastric lesions in rats. 2003 Pharmacol. Res. pmid:12860448
Al-Majed AA et al. Propionyl-L-carnitine prevents the progression of cisplatin-induced cardiomyopathy in a carnitine-depleted rat model. 2006 Pharmacol. Res. pmid:16436331
Sayed-Ahmed MM et al. Propionyl-L-carnitine as potential protective agent against adriamycin-induced impairment of fatty acid beta-oxidation in isolated heart mitochondria. 2000 Pharmacol. Res. pmid:10623482
Marciani P et al. L-carnitine and carnitine ester transport in the rat small intestine. 1991 Pharmacol. Res. pmid:2062791
Riva E and Leopaldi D Control of the cardiac consequences of myocardial ischemia and reperfusion by L-propionylcarnitine: age-response and dose-response studies in the rat heart. 1993 Pediatr. Res. pmid:8255679
Chalmers RA et al. Urinary excretion of l-carnitine and acylcarnitines by patients with disorders of organic acid metabolism: evidence for secondary insufficiency of l-carnitine. 1984 Pediatr. Res. pmid:6441143
Chen PW et al. Stabilization of blood methylmalonic acid level in methylmalonic acidemia after liver transplantation. 2010 Pediatr Transplant pmid:19686300
Kasahara M et al. Living-donor liver transplantation for propionic acidemia. 2012 Pediatr Transplant pmid:22151065
Neri B et al. Differences between carnitine derivatives and coenzyme Q10 in preventing in vitro doxorubicin-related cardiac damages. 1988 Oncology pmid:3368201
Mingorance C et al. Pharmacological effects and clinical applications of propionyl-L-carnitine. 2011 Nutr. Rev. pmid:21521230
Davenport RJ et al. Propionyl-L-carnitine: labelling in the N-methyl position with carbon-11 and pharmacokinetic studies in rats. 1995 Nucl. Med. Biol. pmid:8535330
Roe DS et al. Evidence for a short-chain carnitine-acylcarnitine translocase in mitochondria specifically related to the metabolism of branched-chain amino acids. 2000 Mol. Genet. Metab. pmid:10655160
Löster H et al. Effects of L-carnitine and its acetyl and propionyl esters on ATP and PCr levels of isolated rat hearts perfused without fatty acids and investigated by means of 31P-NMR spectroscopy. 1999 Mol. Cell. Biochem. pmid:10569188
Broderick TL et al. Propionyl-L-carnitine effects on postischemic recovery of heart function and substrate oxidation in the diabetic rat. 2000 Mol. Cell. Biochem. pmid:10839205
Cui J et al. Effects of L-carnitine and its derivatives on postischemic cardiac function, ventricular fibrillation and necrotic and apoptotic cardiomyocyte death in isolated rat hearts. 2003 Mol. Cell. Biochem. pmid:14674702
Motterlini R et al. Functional and metabolic effects of propionyl-L-carnitine in the isolated perfused hypertrophied rat heart. 1992 Mol. Cell. Biochem. pmid:1480142
Pekkinen J et al. Betaine supplementation causes increase in carnitine metabolites in the muscle and liver of mice fed a high-fat diet as studied by nontargeted LC-MS metabolomics approach. 2013 Mol Nutr Food Res pmid:23868375
Riccioni C et al. Rehabilitative treatment in peripheral artery disease: protocol application and follow-up. 2010 Minerva Cardioangiol pmid:20948502
Cotter MA et al. Effects of acetyl- and proprionyl-L-carnitine on peripheral nerve function and vascular supply in experimental diabetes. 1995 Metab. Clin. Exp. pmid:7666797
Brass EP and Beyerinck RA Interactions of propionate and carnitine metabolism in isolated rat hepatocytes. 1987 Metab. Clin. Exp. pmid:3110541
Ferrari R et al. Metabolic modulation and optimization of energy consumption in heart failure. 2003 Med. Clin. North Am. pmid:12693736
Barker GA et al. Effect of propionyl-L-carnitine on exercise performance in peripheral arterial disease. 2001 Med Sci Sports Exerc pmid:11528327
Odiet JA et al. Carnitine palmitoyl transferase-I activity in the aging mouse heart. 1995 Mech. Ageing Dev. pmid:7616763
Hozyasz KK et al. Whole blood propionylcarnitine in newborns with orofacial cleft. 2011 Matern Child Nutr pmid:21470367
Gómez-Amores L et al. Antioxidant activity of propionyl-L-carnitine in liver and heart of spontaneously hypertensive rats. 2006 Life Sci. pmid:16263137
Bueno R et al. L-carnitine and propionyl-L-carnitine improve endothelial dysfunction in spontaneously hypertensive rats: different participation of NO and COX-products. 2005 Life Sci. pmid:15958269
Mister M et al. Propionyl-L-carnitine prevents renal function deterioration due to ischemia/reperfusion. 2002 Kidney Int. pmid:11849462
Azzollini N et al. Propionyl-L-carnitine prevents early graft dysfunction in allogeneic rat kidney transplantation. 2008 Kidney Int. pmid:19008910
Signorelli SS et al. Propionyl-L-carnitine therapy: effects on endothelin-1 and homocysteine levels in patients with peripheral arterial disease and end-stage renal disease. 2006 Kidney Blood Press. Res. pmid:16809937
Sarafoglou K et al. Expanded newborn screening for detection of vitamin B12 deficiency. 2011 JAMA pmid:21427371
Cipolla MJ et al. Propionyl-L-carnitine dilates human subcutaneous arteries through an endothelium-dependent mechanism. 1999 J. Vasc. Surg. pmid:10359944
Loffredo L et al. Imbalance between nitric oxide generation and oxidative stress in patients with peripheral arterial disease: effect of an antioxidant treatment. 2006 J. Vasc. Surg. pmid:16950429
Alvarez de Sotomayor M et al. Effect of L-carnitine and propionyl-L-carnitine on endothelial function of small mesenteric arteries from SHR. 2007 J. Vasc. Res. pmid:17483601
Safarinejad MR et al. Comparison of vitamin E and propionyl-L-carnitine, separately or in combination, in patients with early chronic Peyronie's disease: a double-blind, placebo controlled, randomized study. 2007 J. Urol. pmid:17706714
Cunningham VJ et al. Uptake of [N-methyl-11C]propionyl-L-carnitine (PLC) in human myocardium. 1996 J. Pharmacol. Exp. Ther. pmid:8613961
Hotta N et al. Effect of propionyl-L-carnitine on motor nerve conduction, autonomic cardiac function, and nerve blood flow in rats with streptozotocin-induced diabetes: comparison with an aldose reductase inhibitor. 1996 J. Pharmacol. Exp. Ther. pmid:8558455
Wu X et al. Functional characteristics and tissue distribution pattern of organic cation transporter 2 (OCTN2), an organic cation/carnitine transporter. 1999 J. Pharmacol. Exp. Ther. pmid:10454528
Mancinelli A et al. Uptake of L-carnitine and its short-chain ester propionyl-L-carnitine in the isolated perfused rat liver. 2005 J. Pharmacol. Exp. Ther. pmid:15951397
Marble M et al. Neonatal vitamin B12 deficiency secondary to maternal subclinical pernicious anemia: identification by expanded newborn screening. 2008 J. Pediatr. pmid:18410783
Bogusiewicz A et al. In HepG2 cells, coexisting carnitine deficiency masks important indicators of marginal biotin deficiency. 2015 J. Nutr. pmid:25527659
Brass EP and Ruff LJ Effect of carnitine on propionate metabolism in the vitamin B-12--deficient rat. 1989 J. Nutr. pmid:2778544
Perna AF et al. L-Propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis. 2007 Jan-Feb J. Nephrol. pmid:17347975
Broderick TL et al. L-propionylcarnitine enhancement of substrate oxidation and mitochondrial respiration in the diabetic rat heart. 1996 J. Mol. Cell. Cardiol. pmid:8729065
Kotaka K et al. Reversal of ischemia-induced mitochondrial dysfunction after coronary reperfusion. 1982 J. Mol. Cell. Cardiol. pmid:7108975
Ferrari R et al. Prolonged propionyl-L-carnitine pre-treatment of rabbit: biochemical, hemodynamic and electrophysiological effects on myocardium. 1992 J. Mol. Cell. Cardiol. pmid:1625347
Huemer M et al. Newborn screening for homocystinurias and methylation disorders: systematic review and proposed guidelines. 2015 J. Inherit. Metab. Dis. pmid:25762406
Shigematsu Y et al. Useful second-tier tests in expanded newborn screening of isovaleric acidemia and methylmalonic aciduria. 2010 J. Inherit. Metab. Dis. pmid:20440648
Kuster T et al. Filter paper cards contaminated with EMLA cream produce artefacts on acylcarnitine analysis. 2004 J. Inherit. Metab. Dis. pmid:15669691
Kuhara T et al. Gas chromatographic-mass spectrometric newborn screening for propionic acidaemia by targeting methylcitrate in dried filter-paper urine samples. 2002 J. Inherit. Metab. Dis. pmid:12118533
Wang F et al. Clinical, biochemical, and molecular analysis of combined methylmalonic acidemia and hyperhomocysteinemia (cblC type) in China. 2010 J. Inherit. Metab. Dis. pmid:20924684
Hailemariam D et al. Identification of predictive biomarkers of disease state in transition dairy cows. 2014 J. Dairy Sci. pmid:24630653
Roe CR et al. L-carnitine enhances excretion of propionyl coenzyme A as propionylcarnitine in propionic acidemia. 1984 J. Clin. Invest. pmid:6725560
Hasegawa Y et al. Prenatal diagnosis for organic acid disorders using two mass spectrometric methods, gas chromatography mass spectrometry and tandem mass spectrometry. 2005 J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. pmid:15908288
Delgado C et al. Subacute presentation of propionic acidemia. 2007 J. Child Neurol. pmid:18174561
Torielli L et al. Alterations in energy metabolism of hypertrophied rat cardiomyocytes: influence of propionyl-L-carnitine. 1995 J. Cardiovasc. Pharmacol. pmid:8583777
Micheletti R et al. Effect of propionyl-L-carnitine on the mechanics of right and left papillary muscles from volume-overloaded rat hearts. 1996 J. Cardiovasc. Pharmacol. pmid:8656658
Duncker DJ et al. L-propionylcarnitine does not affect myocardial metabolic or functional response to chronotropic and inotropic stimulation after repetitive ischemia in anesthetized pigs. 1993 J. Cardiovasc. Pharmacol. pmid:7504143
Orlandi A et al. Propionyl-L-carnitine prevents age-related myocardial remodeling in the rabbit. 2007 J. Cardiovasc. Pharmacol. pmid:17703133
Aomine M et al. Electrophysiologic effects of a short-chain acyl carnitine, L-propionylcarnitine, on isolated canine Purkinje fibers. 1989 J. Cardiovasc. Pharmacol. pmid:2471897
Bartels GL et al. Acute improvement of cardiac function with intravenous L-propionylcarnitine in humans. 1992 J. Cardiovasc. Pharmacol. pmid:1383625
Yang XP et al. Hemodynamic and metabolic activities of propionyl-L-carnitine in rats with pressure-overload cardiac hypertrophy. 1992 J. Cardiovasc. Pharmacol. pmid:1383636
Ferrari R and De Giuli F The propionyl-L-carnitine hypothesis: an alternative approach to treating heart failure. 1997 J. Card. Fail. pmid:9330130
Forny P et al. Novel Mouse Models of Methylmalonic Aciduria Recapitulate Phenotypic Traits with a Genetic Dosage Effect. 2016 J. Biol. Chem. pmid:27519416
Ganapathy ME et al. beta-lactam antibiotics as substrates for OCTN2, an organic cation/carnitine transporter. 2000 J. Biol. Chem. pmid:10636865
Orlandi A et al. Propionyl-L-carnitine reduces proliferation and potentiates Bax-related apoptosis of aortic intimal smooth muscle cells by modulating nuclear factor-kappaB activity. 2007 J. Biol. Chem. pmid:17178728
Brass EP et al. Carnitine delays rat skeletal muscle fatigue in vitro. 1993 J. Appl. Physiol. pmid:8282608
Leipälä JA et al. Protection of the reperfused heart by L-propionylcarnitine. 1991 J. Appl. Physiol. pmid:1757378
Brevetti G et al. Propionyl-L-carnitine in intermittent claudication: double-blind, placebo-controlled, dose titration, multicenter study. 1995 J. Am. Coll. Cardiol. pmid:7594063
Brevetti G et al. European multicenter study on propionyl-L-carnitine in intermittent claudication. 1999 J. Am. Coll. Cardiol. pmid:10551714
Serjeant BE et al. Propionyl-L-carnitine in chronic leg ulcers of homozygous sickle cell disease: a pilot study. 1997 J. Am. Acad. Dermatol. pmid:9308570
De Maria P et al. Effect of the addition of electrolytes on the partition coefficients, activity coefficients, and acid dissociation constants of carnitine and its acetyl and propionyl derivatives. 1994 J Pharm Sci pmid:8071833
D'Acquarica I et al. Enantio- and chemo-selective HPLC separations by chiral-achiral tandem-columns approach: the combination of CHIROBIOTIC TAG and SCX columns for the analysis of propionyl carnitine and related impurities. 2004 J Chromatogr A pmid:15641359
Cheng KH et al. Newborn screening for methylmalonic aciduria by tandem mass spectrometry: 7 years' experience from two centers in Taiwan. 2010 J Chin Med Assoc pmid:20603089
Kendler BS Supplemental conditionally essential nutrients in cardiovascular disease therapy. 2006 Jan-Feb J Cardiovasc Nurs pmid:16407731
Hiatt WR et al. Effect of propionyl-L-carnitine on a background of monitored exercise in patients with claudication secondary to peripheral artery disease. 2011 Mar-Apr J Cardiopulm Rehabil Prev pmid:20861750
Tang YM et al. Urine and serum metabolomic profiling reveals that bile acids and carnitine may be potential biomarkers of primary biliary cirrhosis. 2015 Int. J. Mol. Med. pmid:26046127